Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma

This publication has 47 references indexed in Scilit:

• The role of extracellular modulators of canonical Wnt signaling in bone metabolism and diseases
  Seminars in Arthritis and Rheumatism, 2013
• Positive glypican-3 expression in early hepatocellular carcinoma predicts recurrence after hepatectomy
  Journal of Gastroenterology, 2013
• Liver Resection for Transplantable Hepatocellular Carcinoma
  Annals of Surgery, 2009
• Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway
  Carcinogenesis, 2008
• Dysregulation of growth factor signaling in human hepatocellular carcinoma
  Oncogene, 2006
• Processing by Convertases Is Not Required for Glypican-3-induced Stimulation of Hepatocellular Carcinoma Growth
  Journal of Biological Chemistry, 2005
• Glypican-3 Promotes the Growth of Hepatocellular Carcinoma by Stimulating Canonical Wnt Signaling
  Cancer Research, 2005
• Functional binding of secreted molecules to heparan sulfate proteoglycans in Drosophila
  Current Opinion in Cell Biology, 2000
• Glypican-3–Deficient Mice Exhibit Developmental Overgrowth and Some of the Abnormalities Typical of Simpson-Golabi-Behmel Syndrome
  Journal of Cell Biology, 1999
• The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes
  Blood, 1976